Skip to Content Skip to Content

News Archive

Every story published by Penn Today—all in one place.
Reset All Filters
7909 Results
Penn Medicine joins national effort to digitally map the human body

Penn Medicine joins national effort to digitally map the human body

Researchers from the Perelman School of Medicine are joining a national collaboration to launch the Whole Person Physiome Research and Coordination Center, an initiative funded by the National Institutes of Health to create AI-ready models of physiology for research and clinical care.

How tumor mechanics and tiny messengers could shape the future of cancer research

How tumor mechanics and tiny messengers could shape the future of cancer research

A literature review co-written by Penn Engineering Ph.D. student Kshitiz Parihar and Ravi Radhakrishnan, professor in bioengineering and chemical biomolecular engineering, highlights the hidden connections between tumor mechanics and extracellular vesicles (EVs), tiny packages of proteins and genetic material secreted by cells. EVs carry cargo like proteins and RNA between cells, influencing how tumors grow, how the immune system responds, and even how cancers spread to other parts of the body.

Americans’ knowledge of civics increases
A stack of pocket constitutions.

Image: Paul Chinn/San Francisco Chronicle via AP Images

Americans’ knowledge of civics increases

The 2025 Annenberg Constitution Day Civics Survey, released annually to celebrate Constitution Day on Sept. 17, finds that Americans are more knowledgeable this year in answering basic civics questions.

From the Annenberg Public Policy Center

2 min. read

What’s behind the endless breakup-merger cycle?

What’s behind the endless breakup-merger cycle?

Ferrero’s acquisition of WK Kellogg is the latest in the breakup-merger cycle among consumer packaged goods firms. Wharton management professor Emilie Feldman explains why it won’t be the last.

Kiran Musunuru: Editing genes to save lives

Kiran Musunuru: Editing genes to save lives

Kiran Musunuru develops gene-based therapies to improve the health of patients with heart disease and correct genetic changes in people affected by ultra-rare conditions.